BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33058430)

  • 1. The role of platelets in thrombus fibrosis and vessel wall remodeling after venous thrombosis.
    DeRoo E; Martinod K; Cherpokova D; Fuchs T; Cifuni S; Chu L; Staudinger C; Wagner DD
    J Thromb Haemost; 2021 Feb; 19(2):387-399. PubMed ID: 33058430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Clinical Model to Study Recurrent Venous Thrombosis in the Inferior Vena Cava.
    Andraska EA; Luke CE; Elfline MA; Henke SP; Madapoosi SS; Metz AK; Hoinville ME; Wakefield TW; Henke PK; Diaz JA
    Thromb Haemost; 2018 Jun; 118(6):1048-1057. PubMed ID: 29695021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with an oral small molecule inhibitor of P selectin (PSI-697) decreases vein wall injury in a rat stenosis model of venous thrombosis.
    Myers DD; Henke PK; Bedard PW; Wrobleski SK; Kaila N; Shaw G; Meier TR; Hawley AE; Schaub RG; Wakefield TW
    J Vasc Surg; 2006 Sep; 44(3):625-32. PubMed ID: 16950445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
    Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
    J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of cysteine-cysteine receptor 7 promotes fibrotic injury in experimental post-thrombotic vein wall remodeling.
    Laser A; Elfline M; Luke C; Slack D; Shah A; Sood V; Deatrick B; McEvoy B; Ostra C; Comerota A; Kunkel S; Hogaboam C; Henke PK
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):377-85. PubMed ID: 24311382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vein wall remodeling in patients with acute deep vein thrombosis and chronic postthrombotic changes.
    Chandrashekar A; Garry J; Gasparis A; Labropoulos N
    J Thromb Haemost; 2017 Oct; 15(10):1989-1993. PubMed ID: 28787773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects.
    Li W; Kessinger CW; Orii M; Lee H; Wang L; Weinberg I; Jaff MR; Reed GL; Libby P; Tawakol A; Henke PK; Jaffer FA
    Circulation; 2021 Mar; 143(12):1224-1238. PubMed ID: 33445952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recruitment of labelled monocytes by experimental venous thrombi.
    McGuinness CL; Humphries J; Waltham M; Burnand KG; Collins M; Smith A
    Thromb Haemost; 2001 Jun; 85(6):1018-24. PubMed ID: 11434678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute experimental venous thrombosis impairs venous relaxation but not contraction.
    Metz AK; Luke CE; Dowling A; Henke PK
    J Vasc Surg; 2020 Mar; 71(3):1006-1012.e1. PubMed ID: 31248758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of platelet count in a murine stasis model of deep vein thrombosis.
    Mathews R; Setthavongsack N; Le-Cook A; Kaempf A; Loftis JM; Woltjer RL; Lorentz CU; Revenko A; Hinds MT; Nguyen KP
    Platelets; 2024 Dec; 35(1):2290916. PubMed ID: 38099327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The electrolytic inferior vena cava model (EIM) to study thrombogenesis and thrombus resolution with continuous blood flow in the mouse.
    Diaz JA; Alvarado CM; Wrobleski SK; Slack DW; Hawley AE; Farris DM; Henke PK; Wakefield TW; Myers DD
    Thromb Haemost; 2013 Jun; 109(6):1158-69. PubMed ID: 23571406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.
    Payne H; Ponomaryov T; Watson SP; Brill A
    Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
    Sood V; Luke C; Miller E; Mitsuya M; Upchurch GR; Wakefield TW; Myers DD; Henke PK
    Ann Vasc Surg; 2010 Feb; 24(2):233-41. PubMed ID: 20142002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis.
    Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW
    Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the role of receptor interacting protein kinase 3 in venous thrombosis.
    DeRoo E; Khoury M; Zhou T; Yang H; Stranz A; Luke C; Henke P; Liu B
    JVS Vasc Sci; 2022; 3():365-378. PubMed ID: 36568281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep vein thrombosis resolution is not accelerated with increased neovascularization.
    Varma MR; Moaveni DM; Dewyer NA; Varga AJ; Deatrick KB; Kunkel SL; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2004 Sep; 40(3):536-42. PubMed ID: 15337885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid cell tissue factor does not contribute to venous thrombogenesis in an electrolytic injury model.
    Hampton AL; Diaz JA; Hawley AE; Wrobleski SK; Wang JG; Lee RD; Kirchhofer D; Sigler RE; Wakefield TW; Mackman N; Myers DD
    Thromb Res; 2012 Oct; 130(4):640-5. PubMed ID: 22192154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of angiogenic response in local vein wall is associated with reduced thrombus resolution.
    Evans CE; Grover SP; Saha P; Humphries J; Kim JW; Modarai B; Smith A
    Thromb Res; 2014 Sep; 134(3):682-5. PubMed ID: 25042562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution.
    Evans CE; Humphries J; Waltham M; Saha P; Mattock K; Patel A; Ahmad A; Wadoodi A; Modarai B; Burnand K; Smith A
    Thromb Res; 2011 Oct; 128(4):346-51. PubMed ID: 21621825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.
    Deatrick KB; Luke CE; Elfline MA; Sood V; Baldwin J; Upchurch GR; Jaffer FA; Wakefield TW; Henke PK
    J Vasc Surg; 2013 Nov; 58(5):1375-1384.e2. PubMed ID: 23490298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.